Market LIVE
Published markets; coverage varies by country
Product profile · United States

AMVUTTRA

 ·  Patent Litigation & Settlement History ↓

IngredientVUTRISIRAN SODIUM
Application typeNDA
Application215515
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
StrengthEQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)
Approval date2022-06-13
Marketing statusPrescription
Status event—
ApplicantALNYLAM PHARMS INC
Product source

Current GenericRadar decision

Year2036
SelectionCANDIDATE
ReviewFINAL
Anchor typePATENT
Anchor date2036-07-28
Patent anchor2036-07-28
Exclusivity anchor2029-06-13
Protection date2036-07-28
First Final ANDA—
Status event—

GNR judgment: CANDIDATE. Reference year: 2036. Anchor type: PATENT. Patent anchor: 2036-07-28. Exclusivity anchor: 2029-06-13. Anchor date: 2036-07-28. Patent tail: no. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
101319072028-08-24DS/DP/U U-3396YNTRUE_DS
English description not available.
———
101319072028-08-24ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
108067912028-12-04DS —YNTRUE_DS
English description not available.
———
108067912028-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
88289562028-12-04DS/DP/U U-3396YNTRUE_DS
English description not available.
———
88289562028-12-04ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
93705812028-12-04DS/DP/U U-3396YNTRUE_DS
English description not available.
———
93705812028-12-04ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
81060222029-12-12DS/DP/U U-3396YNTRUE_DS
English description not available.
———
81060222029-12-12ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
105703912032-11-16DS/DP/U U-3396YNTRUE_DS
English description not available.
———
105703912032-11-16ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
93997752032-11-16DS/DP/U U-3396YNTRUE_DS
English description not available.
———
93997752032-11-16ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
106120242035-08-14DS/DP/U U-3396YNTRUE_DS
English description not available.
———
106120242035-08-14ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
114015172035-08-14DS/DP/U U-3396YNTRUE_DS
English description not available.
———
114015172035-08-14ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
102083072036-07-28DS/DP/U U-3396YNTRUE_DS
English description not available.
———
102083072036-07-28ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———
106835012036-07-28DS/DP/U U-3396NNU
English description not available.
———
106835012036-07-28ORANGE_BOOK U-3396NNU
English description not available.
———
112864862036-07-28DS/DP/U U-3396NYU
English description not available.
———
112864862036-07-28ORANGE_BOOK U-3396NYU
English description not available.
———
120496282036-07-28DS/DP/U U-3396YNTRUE_DS
English description not available.
———
120496282036-07-28ORANGE_BOOK U-3396YNTRUE_DS
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2022-06-132027-06-13English description not available.YY2027-06-13—Source
NCE2022-06-132027-06-13English description not available.YY2027-06-13
ODE-212 + ODE-527
Full coverage date: 2027-06-13
Source
I-9642025-03-202028-03-20English description not available.NN——Source
I-9642025-03-202028-03-20English description not available.NN—
ODE-212 + ODE-527
Full coverage date: —
Source
ODE-2122022-06-132029-06-13English description not available.NN——Source
ODE-2122022-06-132029-06-13English description not available.NN—
ODE-212 + ODE-527
Full coverage date: —
Source
ODE-5272025-03-202032-03-20English description not available.NN——Source
ODE-5272025-03-202032-03-20English description not available.NN—
ODE-212 + ODE-527
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (18)
TypeDateRoleBasisSource
PATENT2028-08-24HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2029-12-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-11-16HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-11-16HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-08-14HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-08-14HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-07-28CANONICAL_ANCHOREnglish description not available.Source
PATENT2036-07-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-07-28CANONICAL_ANCHOREnglish description not available.Source
PATENT2036-07-28CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2036-07-28CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.